Clinical Trials Browser

Terminated × Head and Neck Neoplasms × clazakizumab × Clear all

NCT01403064 2021-05-11

Safety and Efficacy of ALD518 for Reducing Oral Mucositis in Head and Neck Cancer Subjects

Phase 2 Terminated

76 enrolled 25 charts

Head and Neck Neoplasms, Stomatitis